Logo image of PRPO

PRECIPIO INC (PRPO) Stock Fundamental Analysis

NASDAQ:PRPO - Nasdaq - US74019L6020 - Common Stock - Currency: USD

10.14  +0.5 (+5.19%)

Fundamental Rating

2

Taking everything into account, PRPO scores 2 out of 10 in our fundamental rating. PRPO was compared to 108 industry peers in the Health Care Providers & Services industry. PRPO may be in some trouble as it scores bad on both profitability and health. PRPO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PRPO has reported negative net income.
PRPO had a negative operating cash flow in the past year.
In the past 5 years PRPO always reported negative net income.
PRPO had a negative operating cash flow in each of the past 5 years.
PRPO Yearly Net Income VS EBIT VS OCF VS FCFPRPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

PRPO has a worse Return On Assets (-17.70%) than 76.64% of its industry peers.
With a Return On Equity value of -25.12%, PRPO is not doing good in the industry: 63.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.7%
ROE -25.12%
ROIC N/A
ROA(3y)-39.03%
ROA(5y)-50.48%
ROE(3y)-50.05%
ROE(5y)-69.83%
ROIC(3y)N/A
ROIC(5y)N/A
PRPO Yearly ROA, ROE, ROICPRPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400 -600 -800

1.3 Margins

With a decent Gross Margin value of 39.78%, PRPO is doing good in the industry, outperforming 67.29% of the companies in the same industry.
PRPO's Gross Margin has improved in the last couple of years.
PRPO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28%
GM growth 5Y37.55%
PRPO Yearly Profit, Operating, Gross MarginsPRPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

PRPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PRPO has more shares outstanding
Compared to 5 years ago, PRPO has more shares outstanding
PRPO has a better debt/assets ratio than last year.
PRPO Yearly Shares OutstandingPRPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M
PRPO Yearly Total Debt VS Total AssetsPRPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -6.61, we must say that PRPO is in the distress zone and has some risk of bankruptcy.
PRPO's Altman-Z score of -6.61 is on the low side compared to the rest of the industry. PRPO is outperformed by 89.72% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that PRPO is not too dependend on debt financing.
The Debt to Equity ratio of PRPO (0.02) is better than 81.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -6.61
ROIC/WACCN/A
WACC8.95%
PRPO Yearly LT Debt VS Equity VS FCFPRPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

PRPO has a Current Ratio of 0.73. This is a bad value and indicates that PRPO is not financially healthy enough and could expect problems in meeting its short term obligations.
PRPO's Current ratio of 0.73 is on the low side compared to the rest of the industry. PRPO is outperformed by 87.85% of its industry peers.
A Quick Ratio of 0.60 indicates that PRPO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.60, PRPO is doing worse than 85.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.6
PRPO Yearly Current Assets VS Current LiabilitesPRPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.67% over the past year.
The Revenue has grown by 31.30% in the past year. This is a very strong growth!
PRPO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.66% yearly.
EPS 1Y (TTM)72.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.34%
Revenue 1Y (TTM)31.3%
Revenue growth 3Y35.64%
Revenue growth 5Y39.66%
Sales Q2Q%15.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y106.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year65.19%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRPO Yearly Revenue VS EstimatesPRPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRPO Yearly EPS VS EstimatesPRPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRPO. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 25.49, PRPO can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as PRPO.
PRPO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 25.49
PRPO Price Earnings VS Forward Price EarningsPRPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRPO Per share dataPRPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PRPO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PRPO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRECIPIO INC

NASDAQ:PRPO (2/21/2025, 8:00:01 PM)

10.14

+0.5 (+5.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)03-31 2025-03-31/amc
Inst Owners4.95%
Inst Owner Change-84.48%
Ins Owners12.6%
Ins Owner Change0.95%
Market Cap15.01M
Analysts82.86
Price TargetN/A
Short Float %1.79%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-28.12%
Min Revenue beat(2)-30.04%
Max Revenue beat(2)-26.2%
Revenue beat(4)0
Avg Revenue beat(4)-25.24%
Min Revenue beat(4)-31.33%
Max Revenue beat(4)-13.39%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.49
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)0.4
Fwd EY3.92%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS11.76
BVpS8.07
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.7%
ROE -25.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.78%
FCFM N/A
ROA(3y)-39.03%
ROA(5y)-50.48%
ROE(3y)-50.05%
ROE(5y)-69.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28%
GM growth 5Y37.55%
F-Score4
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.52%
Cap/Sales 1.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.6
Altman-Z -6.61
F-Score4
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)28.66%
Cap/Depr(5y)20.84%
Cap/Sales(3y)3.83%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.34%
EPS Next Y106.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.3%
Revenue growth 3Y35.64%
Revenue growth 5Y39.66%
Sales Q2Q%15.29%
Revenue Next Year65.19%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y96.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.8%
OCF growth 3YN/A
OCF growth 5YN/A